StemGen, Inc.
SGNI · OTC
6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | |
|---|---|---|---|---|
| Market Cap | $46 | $36 | $26 | $15 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $46 | $37 | $26 | $16 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 101.6% | -12.3% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 21.9% | 55.7% | 61.4% | – |
| EBITDA | -$0 | -$0 | -$0 | $0 |
| % Margin | -461.2% | -364.9% | -1,396.3% | – |
| Net Income | -$0 | -$0 | -$0 | $0 |
| % Margin | -1,110.3% | -1,192.6% | -1,931.3% | – |
| EPS Diluted | -0.01 | -0.008 | -0.02 | 0 |
| % Growth | -15.9% | 59% | -5,100% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |